English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

There has been a marked increase in the number of patients in the UK taking opioids from 2.5% in 2000 to 5% in 2015.1 More patients are taking opioids at higher doses for chronic pain,2,3 for which there is limited evidence of effectiveness.A public facing4 audit with educational resources of high-dose opioids (≥120 mg oral morphine equivalent [OME]) prescribed for chronic pain was carried out in 74 general practices in the East of England, representing 663 418 patients.The dose of ≥120 mg OME was chosen as doses above this are not associated with increased benefit but are associated with increased harms.2 The aim of this study was to quantify:This study also aimed to record practice reflections and plans on their results.In total, 517 practices throughout NHS England Midland and East (East) were emailed (January 2018), inviting participation in an audit of high-dose opioids prescribed for chronic pain. Downloadable searches were provided. It was suggested that …

Opioids Aware: a general practice audit of high-dose opioid prescribing NHS England Midlands and East